Axonics (NASDAQ: AXNX) reported quarterly earnings of $0.08 per share which beat the analyst consensus estimate of $(0.05) by 260 percent. This is a 123.53 percent increase over losses of $(0.34) per share from the same period last year. The company reported quarterly sales of $93.10 million which beat the analyst consensus estimate of $89.73 million by 3.76 percent. This is a 32.27 percent increase over sales of $70.38 million the same period last year.